Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
4.96
0.59 (13.63%)
At close: Jun 17, 2025, 1:45 PM
13.63% (1D)
| Bid | 4.59 |
| Market Cap | 2.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.33M |
| EPS (ttm) | -612.99 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 5.09 |
| Volume | 270,902 |
| Avg. Volume (20D) | 86,603 |
| Open | 4.69 |
| Previous Close | 4.37 |
| Day's Range | 4.39 - 5.43 |
| 52-Week Range | 2.94 - 702.00 |
| Beta | 0.15 |
5 months ago
-25.16%
Psyence Biomedical shares are trading lower after ...
Unlock content with
Pro Subscription
5 months ago
+60.78%
Psyence Biomedical shares are trading higher. The company announced it has entered into an IP licensing and mutual exclusivity agreement with Optimi Health Corp.
1 month ago · newsfilecorp.com
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock SplitNew York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share consolidation ...
2 months ago · newsfilecorp.com
Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNew York, New York--(Newsfile Corp. - April 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") announced today that it received a notification letter dated April 16,...
